Status:
TERMINATED
Preemptive Lung Impedance-guided Therapy of Evolving Acute Heart Failure in Acute Myocardial Infarction Patients
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Acute Heart Failure
Eligibility:
All Genders
Phase:
NA
Brief Summary
It is well known that 20-25% of patients hospitalized for acute myocardial infarction will develop acute heart failure during their hospitalization. Currently, the investigators have no reliable param...
Eligibility Criteria
Inclusion
- Patients hospitalized in the ICCU for acute myocardial infarction and developing acute heart failure during their hospitalization
Exclusion
- Patients with acute myocardial infarction with clinical and radiological signs of acute heart failure at admission
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01264159
Start Date
January 1 2011
End Date
July 1 2015
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel, 38100